MedPath
TGA Approval

KOMBIGLYZE XR 5/500 tablets 5 mg saxagliptin (as hydrochloride) immediate release and 500 mg metformin hydrochloride modified release (202209)

202209

KOMBIGLYZE XR 5/500 tablets 5 mg saxagliptin (as hydrochloride) immediate release and 500 mg metformin hydrochloride modified release

AstraZeneca Pty Ltd

October 10, 2013

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/d0b993c88e7e08b198854593358c5e38.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/0aad235579b2b82c4e39d9181215dc88.pdf

Active Ingredients

metformin hydrochloride

saxagliptin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

KOMBIGLYZE XR 5/500 tablets 5 mg saxagliptin (as hydrochloride) immediate release and 500 mg metformin hydrochloride modified release (202209) - TGA 批准文号 | MedPath